Copyright
©The Author(s) 2021.
World J Gastroenterol. Sep 28, 2021; 27(36): 6093-6109
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6093
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6093
Figure 10 Interaction of KRAS, SMAD4 (DPC4), and BRCA2 with other genes based on various parameters.
KRAS: Kirsten rat sarcoma; DPC-4: Deleted in pancreatic cancer-4; BRCA-2: Breast cancer type 2.
- Citation: Rah B, Banday MA, Bhat GR, Shah OJ, Jeelani H, Kawoosa F, Yousuf T, Afroze D. Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer. World J Gastroenterol 2021; 27(36): 6093-6109
- URL: https://www.wjgnet.com/1007-9327/full/v27/i36/6093.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i36.6093